Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer

NCT04947189 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Triple Negative Breast Cancer

Interventions

DRUG: Seviteronel-D (Seivteronel in combination with dexamethasone)
DRUG: Docetaxel

Sponsor

St Vincent's Hospital, Sydney